Drug Database
Back to search

France· FR:62999444

BARITEKAL 20 mg/ml, solution injectable

A prilocaine product containing chlorhydrate de prilocaïne, registered in France by NORDIC GROUP (PAYS-BAS). The same ATC class is registered in 14 of our 19 countries.

ATC N01BB04

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedBARITEKAL 20 mg/ml, solution injectab…ATCN01BB04REGISTER NO.FR:62999444PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about chlorhydrate de prilocaïneAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Prilocaine is registered in 14 of 19 countries.

Countries holding a registration under ATC N01BB04 (prilocaine), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 8 of them publish a price we can compare per daily dose
Search prilocaine products by name

Prilocaine · ATC N01BB04

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
CHLORHYDRATE DE PRILOCAÏNE
Manufacturer
NORDIC GROUP (PAYS-BAS)
Country
France (FR)
ATC code
N01BB04
ATC class
Prilocaine
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400958589638
    10 ampoule(s) en verre de 5 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

39 interactions on record for prilocaine.

Graded by severity as the source publishes them — 36 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check prilocaine against other medicinesHow interaction checks work

Prilocaine · interactions on record

39 records

  • 36 severe
  • 2 moderate
  • 1 minor

Most severe, free to view

  • LidocainA01AE01severe
  • TetracainA01AE02severe
  • MetoclopramideA03FA01severe
  • SulfasalazineA07EC01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Prilocaine in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All prilocaine products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

  • Austria · Takipril Hyperbar
  • Belgium · Citanest, Citanest 1%
  • Bulgaria · Такиприл
  • Germany · Takipril, Xylonest
  • Denmark · Takipril
  • Spain · Takipril Hiperbárica
  • Finland · Takipril
  • United Kingdom (Northern Ireland) · Prilocaine Hydrochloride, Prilotekal
  • Hungary · Prilotekal
  • Italy · Prilotekal
  • Luxembourg · Citanest, Citanest 1%
  • Netherlands · Citanest 1 %, Citanest 2 %
  • Norway · Takipril
  • Poland · Prilotekal
  • Sweden · Citanest, Takipril
  • Slovakia · Prilotekal

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5f739297-33f8-4ee6-afc3-5d09f221af7b
GET /v1/drugs/5f739297-33f8-4ee6-afc3-5d09f221af7b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "62999444",
  "date_amm": "2014-01-22",
  "type_amm": "Procédure de reconnaissance mutuelle",
  "numero_ue": null,
  "substance": "CHLORHYDRATE DE PRILOCAÏNE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution injectable",
  "voies_administration": "intrathécale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about prilocaine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console